Evotec SE (EVO) Beginning Cash Balance (2009 - 2023)
Evotec SE (EVO) posted Beginning Cash Balance of $784879.9 for Q1 2022, up 53.98% sequentially from $509731.3 in Q1 2021, and up 53.98% YoY from $509731.3 in Q1 2021.
Evotec SE (EVO) Beginning Cash Balance (2009 - 2023) Analysis & Trends
Evotec SE has reported Beginning Cash Balance for 3 years, with the latest figure at $784879.9 in Q1 2022.
- Quarterly Beginning Cash Balance rose 53.98% year-over-year to $784879.9 in Q1 2022, while the trailing twelve-month figure through Sep 2022 was $784879.9 (up 53.98% YoY) and the FY2009 annual result came in at $76.8 million, changed N/A from the prior year.
- Beginning Cash Balance advanced to $784879.9 in Q1 2022 per EVO's latest filing, from $509731.3 in the prior quarter.
- Over five years, Beginning Cash Balance peaked at $784879.9 in Q1 2022 and troughed at $509731.3 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Evotec SE | 687.23 Mn | 686.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 452,072.41 |
| Jun 30, 2023 | 452,072.41 |
| Sep 30, 2022 | 705,112.45 |
| Sep 30, 2022 | 705,112.45 |
| Jun 30, 2022 | 746,220.49 |
| Jun 30, 2022 | 746,220.49 |
| Mar 31, 2022 | 784,879.95 |
| Mar 31, 2022 | 784,879.95 |
| Mar 31, 2021 | 509,731.26 |
| Mar 31, 2021 | 509,731.26 |
| Mar 31, 2009 | 72.01 Mn |
| Mar 31, 2009 | 72.01 Mn |